NCT03259503 2025-11-10Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1 Completed50 enrolled
NCT00992446 2020-03-18Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaFred Hutchinson Cancer CenterPhase 2 Completed27 enrolled 13 charts
NCT01567709 2018-04-11Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed34 enrolled